Frontiers in Oncology, 2234-943X

Journal

Publications

  1. 2020
  2. Published
  3. 2019
  4. Published

    A perspective on polo-like kinase-1 inhibition for the treatment of rhabdomyosarcoma

    Susanne Gatz, Pamela Kearns, 22 Nov 2019, In : Frontiers in Oncology. 9, 7 p., 1271.

    Research output: Contribution to journalReview article

  5. Published
  6. 2018
  7. Published
  8. Published
  9. Published
  10. Published
  11. 2015
  12. Published

    Challenges of clinical trial design for targeted agents against pediatric leukemias

    Christina Yap & Pamela Kearns, 6 Jan 2015, In : Frontiers in Oncology. 4, p. 374 1 p.

    Research output: Contribution to journalArticle